Plastic Ampoules Production Facility (EBRD-49334)

Countries
  • Uzbekistan
Where the impacts of the investment may be experienced.
Financial Institutions
  • European Bank for Reconstruction and Development (EBRD)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Proposed
Bank Risk Rating
B
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Oct 18, 2017
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
Borrower
MUTABAR MEDICAL STANDART LLC
The holder of the loan, grant, or other investment.
Sectors
  • Construction
  • Industry and Trade
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Loan
The categories of the bank investment: loan, grant, etc.
Investment Amount (USD)
$ 11.18 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Project Cost (USD)
$ 17.56 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please see updated project documentation for more information.
Primary Source

Original disclosure @ EBRD website

Updated in EWS Apr 5, 2018

Disclosed by Bank Sep 13, 2017


Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description

This project finances the construction of a new pharmaceutical production plant and installation of fully automated equipment, with a maximum capacity of 280 million plastic ampoules of injectables.

 

Investment Description
  • European Bank for Reconstruction and Development (EBRD)

Mutabar Medical Standart LLC is a newly established company in Uzbekistan specifically for the Project implementation. The Borrower is 100 per cent owned by Jurabek Laboratories LLC, the "Sponsor", which is the largest local pharmaceutical production company in Uzbekistan.

The remaining financing for this project is being provided by Jurabek Laboratories.

Contact Information

Davron Abdullaev
info@mutabar.uz
+998909415599
+998711500303
http://www.mutabar.uz
«Mutabar Medical Standart» LTD, Porloq street, Tashkent, Uzbekistan

ACCOUNTABILITY MECHANISM OF EBRD
The Project Complaint Mechanism (PCM) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an European Bank for Reconstruction and Development (EBRD)-financed project. If you submit a complaint to the PCM, it may assess compliance with EBRD's own policies and procedures to prevent harm to the environment or communities or it may assist you in resolving the problem that led to the complaint through a dialogue with those implementing the project. Additionally, the PCM has the authority to recommend a project be suspended in the event that harm is imminent. You can contact the PCM at pcm@ebrd.com or you can submit a complaint online using an online form, http://www.ebrd.com/eform/pcm/complaint_form?language=en. You can learn more about the PCM and how to file a complaint at http://www.ebrd.com/work-with-us/project-finance/project-complaint-mechanism.html.